Pharmaceutical compounds and compositions that degrade the matrix-associated actin-dependent chromatin a subfamily regulator related to swi / snf

CO20260006266A2Pending Publication Date: 2026-07-21PLEXIUM INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
PLEXIUM INC
Filing Date
2026-05-07
Publication Date
2026-07-21
Patent Text Reader

Abstract

Compounds are described that are useful for modulating or degrading the protein expressed from one or more matrix-associated actin-dependent regulators related to SWI / SNF of the chromatin subfamily A (SMARCA) (e.g., SMARCA2 and / or SMARCA4).
Need to check novelty before this filing date? Find Prior Art